Vitality Biopharma Announces Positive Results for Colon Cancer
March 30, 2017 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Mar 30, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity
March 02, 2017 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Mar 2, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma to Present at SeeThruEquity 3rd Annual Innovations Investor Conference in Miami
February 16, 2017 08:55 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Feb 16, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
February 01, 2017 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Feb 1, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company"), a corporation dedicated to the development of cannabinoid...
Vitality Biopharma to Present at Biotech Showcase 2017
January 09, 2017 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Jan 9, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Receives DEA Approval for Cannabinoid Pharma Development Facility
December 21, 2016 08:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Dec 21, 2016) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company"), a corporation dedicated to the development of...
Vitality Biopharma Advances Cannabosides for Treatment of Narcotic Bowel Syndrome
November 16, 2016 08:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Nov 16, 2016) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Announces International Patent Filing for Cannabinoid Pharmaceuticals
November 09, 2016 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Nov 9, 2016) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Reports on Initial Cannabinoid Drug Formulation Studies
October 19, 2016 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 19, 2016) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Develops Cannabinoid Alternatives to Opiate Prescription Pain Medications
September 13, 2016 09:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Sep 13, 2016) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...